从资金流向上来看，当日生物制品板块主力资金净流入3.99亿元，游资资金净流出6286.66万元，散户资 金净流出3.36亿元。生物制品板块个股资金流向见下表： 证券之星消息，1月13日生物制品板块较上一交易日上涨1.15%，康乐卫士领涨。当日上证指数报收于 4138.76，下跌0.64%。深证成指报收于14169.4，下跌1.37%。生物制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 920575 | 康乐卫士 | 11.99 | 29.90% | 35.12万 | | 4.02亿 | | 688331 | 荣昌生物 | 114.46 | 20.00% | 21.22万 | | 23.69亿 | | 688137 | 沂岸蛋白 | 49.60 | 15.43% | 5.81万 | | 2.91亿 | | 920344 | 三元基因 | 28.45 | 11.44% | 6.86万 | | 1.94亿 | | 301047 | 义翘神州 | 82.02 | ...

Core Insights - Beijing Yiqiao Shenzhou Technology Co., Ltd. has been awarded the "2025 Supplier Performance Recognition Award" by Scientist.com for its outstanding contributions and performance in advancing global drug discovery research [1][3]. Company Overview - Yiqiao Shenzhou is an international reagent supplier and contract research service provider, focusing on recombinant protein production and antibody development. The company operates under a strict quality management system, offering unique biological reagents for fields such as cell therapy, stem cell research, and infectious disease research [5]. Performance Metrics - The Supplier Performance Recognition Award is given to partners that excel in key performance indicators such as responsiveness, marketplace activity, and customer satisfaction. Yiqiao Shenzhou achieved a responsiveness rate of 90%, contributing significantly to global research efficiency [3][4]. Service Offerings - In 2025, Yiqiao Shenzhou provided critical technical services through the Scientist.com platform, covering areas such as protein biology, antibody development, in vitro testing, in vitro pharmacology, and innovative drug CMC [4]. - The company offers a one-stop service from gene synthesis to protein expression and purification using four major systems: mammalian cells, baculovirus-insect cells, E. coli, and cell-free expression systems [4]. Collaboration and Recognition - Yiqiao Shenzhou has developed over 30,000 antibodies and established strong partnerships with many international pharmaceutical companies, highlighting its leading position in the global life sciences research and drug development sector [4][5]. - The Chief Business Officer of Yiqiao Shenzhou expressed pride in the recognition from Scientist.com and emphasized the company's commitment to providing reliable, timely, and innovative solutions for the global scientific community [5]. Industry Context - Scientist.com is a leading AI-driven procurement platform in the life sciences sector, connecting researchers with a global network of over 6,000 suppliers to accelerate scientific discovery [6].

Core Viewpoint - The announcement indicates that the controlling shareholder, Ailike, has pledged 6 million shares to Huaneng Guicheng Trust Co., Ltd., which represents 9.21% of Ailike's holdings and 4.93% of the company's total share capital [1] Summary by Relevant Categories Share Pledge Details - Ailike pledged 6 million shares, starting from December 22, 2025, for financing purposes [1] - The total pledged shares by Ailike and its concerted parties amount to 25.6 million shares, which is 37.71% of their total holdings and 21.05% of the company's total share capital [1] Risk Assessment - The pledged shares do not pose a risk of forced liquidation and will not have a substantial impact on the company [1]

证券代码：301047 证券简称：义翘神州 公告编号：2025-049 2、股东股份累计质押基本情况 北京义翘神州科技股份有限公司 关于控股股东部分股份质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股东股份质押基本情况 北京义翘神州科技股份有限公司（以下简称"公司"）于近日收到公司控股 股东拉萨爱力克投资咨询有限公司（以下简称"爱力克"）的通知，获悉其所持 有公司的部分股份办理了质押业务，具体事项如下： 截至公告披露日，上述股东及其一致行动人所持质押股份情况如下： | 质押到 | 股东 | 是否为控股 股东或第一 | 本次质押数 | 占其所 | 占公司 | 是否 | 是否为 | 质押起 | | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 期日 | 名称 | 大股东及其 | 量（股） | 持股份 | 总股本 | 为限 | 补充质 | 始日 | 质权人 | 用途 | | | | 一致行动人 | | 比例 | 比例 | 售股 | 押 | | | ...

Group 1 - The company Yiqiao Shenzhou reported that as of December 19, 2025, the number of shareholders is 19,539 [2]

Group 1 - The company Yiqiao Shenzhou (301047) announced that as of December 10, 2025, the number of shareholders will be 19,393 [1]

Core Viewpoint - Yiqiao Shenzhou has completed the business registration and filing procedures, obtaining a business license from the Beijing Economic and Technological Development Zone Market Supervision Administration [2] Group 1 - The company has successfully registered its business and completed necessary documentation [2] - The business license was issued by the relevant market supervision authority in Beijing [2]

证券代码：301047 证券简称：义翘神州 公告编号：2025-048 北京义翘神州科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 北京义翘神州科技股份有限公司（以下简称"公司"）分别于 2025 年 11 月 18 日、2025 年 12 月 4 日召开了第二届董事会第十八次会议、2025 年第二次 临时股东大会，审议通过了《关于变更公司类型的议案》《关于修订<公司章程> 的议案》等议案。具体内容详见公司 2025 年 11 月 19 日、2025 年 12 月 4 日在 巨潮资讯网(www.cninfo.com.cn)上披露的相关公告。 近日，公司完成了工商变更登记和备案手续，并取得了北京经济技术开发区 市场监督管理局颁发的《营业执照》，相关信息如下： 名称：北京义翘神州科技股份有限公司 统一社会信用代码：91110302MA00AR3F76 注册资本：12,163.6742 万元 成立日期：2016 年 12 月 22 日 法定代表人：张杰 住所：北京市北京经济技术开发区景园街 8 号院 1 号 ...

证券日报网讯 12月9日晚间，义翘神州发布公告称，控股股东拉萨爱力克投资咨询有限公司解除质押 15，000，000股，占其所持股份23.03%，占公司总股本12.33%，解除日期为2025年12月8日。 （文章来源：证券日报） ...

南财智讯12月9日电，义翘神州公告，北京义翘神州科技股份有限公司于近日收到公司控股股东拉萨爱 力克投资咨询有限公司（以下简称"爱力克"）的通知，获悉其所持有公司的部分股份办理了解除质押业 务。本次解除质押股份数量为1500.00万股，占其所持股份比例的23.03%，占公司总股本比例的 12.33%。截至公告披露日，爱力克累计被质押股份1960.00万股，占其所持股份比例的30.09%，占公司 总股本比例的16.11%。谢良志及其一致行动人合计持股6788.16万股，合计被质押股份1960.00万股，占 公司总股本比例的16.11%。 ...